-検索条件
-検索結果
検索 (著者・登録者: li & wr)の結果975件中、1から50件目までを表示しています
![](data/emdb/media/18051/emdbimg.jpg)
EMDB-18051:
Inward-facing, closed proteoliposome complex I at 3.1 A. Initially purified in DDM.
![](data/emdb/media/18052/emdbimg.jpg)
EMDB-18052:
Inward-facing, open2 proteoliposome complex I at 3.1 A. Initially purified in DDM.
![](data/emdb/media/18054/emdbimg.jpg)
EMDB-18054:
Inward-facing, slack proteoliposome complex I at 3.1 A. Initially purified in DDM.
![](data/emdb/media/18055/emdbimg.jpg)
EMDB-18055:
Outward-facing, closed proteoliposome complex I at 3.1 A. Initially purified in DDM.
![](data/emdb/media/18057/emdbimg.jpg)
EMDB-18057:
Outward-facing, open2 proteoliposome complex I at 3.1 A. Initially purified in DDM.
![](data/emdb/media/18059/emdbimg.jpg)
EMDB-18059:
Outward-facing, slack proteoliposome complex I at 3.1 A. Initially purified in DDM.
![](data/emdb/media/18066/emdbimg.jpg)
EMDB-18066:
Inward-facing, open2 proteoliposome complex I at 2.9 A, after deactivation treatment. Initially purified in LMNG.
![](data/emdb/media/18067/emdbimg.jpg)
EMDB-18067:
Inward-facing, open1 proteoliposome complex I at 3.3 A, after deactivation treatment. Initially purified in LMNG.
![](data/emdb/media/18068/emdbimg.jpg)
EMDB-18068:
Outward-facing, open2 proteoliposome complex I at 2.6 A, after deactivation treatment. Initially purified in LMNG.
![](data/emdb/media/18069/emdbimg.jpg)
EMDB-18069:
Outward-facing, open1 proteoliposome complex I at 2.8 A, after deactivation treatment. Initially purified in LMNG.
![](data/emdb/media/18138/emdbimg.jpg)
EMDB-18138:
Inward-facing, closed proteoliposome complex I at 2.7 A. Initially purified in LMNG.
![](data/emdb/media/18139/emdbimg.jpg)
EMDB-18139:
Inward-facing, open2 proteoliposome complex I at 2.6 A. Initially purified in LMNG.
![](data/emdb/media/18140/emdbimg.jpg)
EMDB-18140:
Inward-facing, open1 proteoliposome complex I at 2.9 A. Initially purified in LMNG.
![](data/emdb/media/18141/emdbimg.jpg)
EMDB-18141:
Outward-facing, closed proteoliposome complex I at 2.5 A. Initially purified in LMNG.
![](data/emdb/media/18142/emdbimg.jpg)
EMDB-18142:
Outward-facing, open2 proteoliposome complex I at 2.6 A. Initially purified in LMNG.
![](data/emdb/media/18143/emdbimg.jpg)
EMDB-18143:
Outward-facing, open1 proteoliposome complex I at 2.6 A. Initially purified in LMNG.
![](data/pdb/img/8q0a.jpg)
PDB-8q0a:
Inward-facing, closed proteoliposome complex I at 3.1 A. Initially purified in DDM.
![](data/pdb/img/8q0f.jpg)
PDB-8q0f:
Inward-facing, open2 proteoliposome complex I at 3.1 A. Initially purified in DDM.
![](data/pdb/img/8q0j.jpg)
PDB-8q0j:
Inward-facing, slack proteoliposome complex I at 3.8 A. Initially purified in DDM.
![](data/pdb/img/8q0m.jpg)
PDB-8q0m:
Outward-facing, closed proteoliposome complex I at 3.1 A. Initially purified in DDM.
![](data/pdb/img/8q0o.jpg)
PDB-8q0o:
Outward-facing, open2 proteoliposome complex I at 3.1 A. Initially purified in DDM.
![](data/pdb/img/8q0q.jpg)
PDB-8q0q:
Outward-facing, slack proteoliposome complex I at 3.6 A. Initially purified in DDM
![](data/pdb/img/8q1p.jpg)
PDB-8q1p:
Inward-facing, open2 proteoliposome complex I at 2.9 A, after deactivation treatment. Initially purified in LMNG.
![](data/pdb/img/8q1u.jpg)
PDB-8q1u:
Inward-facing, open1 proteoliposome complex I at 3.3 A, after deactivation treatment. Initially purified in LMNG.
![](data/pdb/img/8q1y.jpg)
PDB-8q1y:
Outward-facing, open2 proteoliposome complex I at 2.6 A, after deactivation treatment. Initially purified in LMNG.
![](data/pdb/img/8q25.jpg)
PDB-8q25:
Outward-facing, open1 proteoliposome complex I at 2.8 A, after deactivation treatment. Initially purified in LMNG.
![](data/pdb/img/8q45.jpg)
PDB-8q45:
Inward-facing, closed proteoliposome complex I at 2.7 A. Initially purified in LMNG.
![](data/pdb/img/8q46.jpg)
PDB-8q46:
Inward-facing, open2 proteoliposome complex I at 2.6 A. Initially purified in LMNG.
![](data/pdb/img/8q47.jpg)
PDB-8q47:
Inward-facing, open1 proteoliposome complex I at 2.9 A. Initially purified in LMNG.
![](data/pdb/img/8q48.jpg)
PDB-8q48:
Outward-facing, closed proteoliposome complex I at 2.5 A. Initially purified in LMNG.
![](data/pdb/img/8q49.jpg)
PDB-8q49:
Outward-facing, open2 proteoliposome complex I at 2.6 A. Initially purified in LMNG.
![](data/pdb/img/8q4a.jpg)
PDB-8q4a:
Outward-facing, open1 proteoliposome complex I at 2.6 A. Initially purified in LMNG.
![](data/emdb/media/29330/emdbimg.jpg)
EMDB-29330:
N332-GT5 SOSIP in complex with base polyclonal Fabs isolated at day 42 from protein immunized wild type mice
![](data/emdb/media/29333/emdbimg.jpg)
EMDB-29333:
N332-GT5 SOSIP in complex with base polyclonal Fabs isolated at day 42 from protein immunized BG18HCgl knock-in mice
![](data/emdb/media/29334/emdbimg.jpg)
EMDB-29334:
N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 16 from mRNA immunized wild type mice
![](data/emdb/media/29335/emdbimg.jpg)
EMDB-29335:
N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 42 from mRNA immunized BG18HCgl knock-in mice
![](data/emdb/media/43191/mapi/surf_x.jpg)
EMDB-43191:
N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 14 from N332-GT2 nanoparticle-immunized BG18HCgl knock-in mice
![](data/emdb/media/43192/mapi/surf_y.jpg)
EMDB-43192:
N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 15 from N332-GT5 nanoparticle-immunized BG18HCgl knock-in mice
![](data/emdb/media/40786/emdbimg.jpg)
EMDB-40786:
Structural basis and functional roles for Toll-like receptor binding to Latrophilin adhesion-GPCR in embryo development
![](data/emdb/media/43529/mapi/surf_x.jpg)
EMDB-43529:
L5A7 Fab bound to Indonesia2005 Hemagglutinin
![](data/emdb/media/43545/mapi/surf_x.jpg)
EMDB-43545:
L5A7 Fab bound to 28H6E11 anti-idiotype Fab
![](data/pdb/img/8vue.jpg)
PDB-8vue:
L5A7 Fab bound to Indonesia2005 Hemagglutinin
![](data/pdb/img/8vuz.jpg)
PDB-8vuz:
L5A7 Fab bound to 28H6E11 anti-idiotype Fab
![](data/emdb/media/40825/emdbimg.jpg)
EMDB-40825:
10E8-GT10.2 immunogen in complex with human Fab 10E8 and mouse Fab W6-10
![](data/emdb/media/40815/emdbimg.jpg)
EMDB-40815:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies C3V5, V1V3, N611 and base from participant 017
![](data/emdb/media/40816/emdbimg.jpg)
EMDB-40816:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies gp41-N611/FP and base from participant 03
![](data/emdb/media/40817/emdbimg.jpg)
EMDB-40817:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies gp41-N611/FP and base from participant 07
![](data/emdb/media/40818/emdbimg.jpg)
EMDB-40818:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies gp120-GH and base from participant 09
![](data/emdb/media/40819/emdbimg.jpg)
EMDB-40819:
BG505 SOSIP.664 in complex with wk26 human polyclonal antibodies C3V5, V1V3, gp41-GH/FP and base from participant 11
![](data/emdb/media/28937/emdbimg.jpg)
EMDB-28937:
N332-GT5 SOSIP in complex with V1V3 polyclonal Fabs isolated at day 42 from protein immunized wild type mice
ページ: